top of page
RECRUITING · PHASE 3
CLARITY-AMR: Rapid Diagnostics for Resistant Bloodstream Infections
Evaluating whether rapid molecular diagnostics improve timely, targeted treatment for resistant bloodstream infections.
About this study
Evaluating whether rapid molecular diagnostics improve timely, targeted treatment for resistant bloodstream infections.
Study sponsor
Africa Infectious Disease Research Consortium
STUDY AT A GLANCE
STATUS
Small Title
CONDICTION
Antimicrobial Resistance
PHASE
Phase 3
ENROLLMENT
840
bottom of page